CD 34+ Cell Therapy is Associated with Improved Myocardial Perfusion in Heart Failure with Preserved Ejection Fraction

Purpose: In HFpEF patients transendocardial CD34+ cell therapy was shown to improve systolic and diastolic properties of the target myocardium. However, the underlying mechanisms remain poorly defined. We sought to evaluate the potential correlation between CD34+ cell therapy and myocardial perfusion in HFpEF patients.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , R. Zba čnik, S. Frljak, G. Zemljic, A. Cerar, N. Žorž, R. Okrajsek, M. Sebestjen, B. Vrtovec Source Type: research